Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium). A Randomized, Placebo-controlled, Double-blind, Multicenter Phase III Study.

NCT00951574 is registered in ClinicalTrials.gov with Italfarmaco as lead sponsor.

NCT NCT00951574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00951574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium). A Randomized, Placebo-controlled, Double-blind, Multicenter Phase III Study.
Lead sponsor
Italfarmaco
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2003
Completion date
July 31, 2008
Enrollment
1,166 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, metastatic cancer